Costly new breast cancer therapies augment the significant burden this disease places on healthcare resources, but in context they may still provide value to society.
David J. Rak, MPH
Advertisement
Articles by David J. Rak, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5